Sofia Sirvent
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sofia Sirvent has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Clare L. Bennett
Institute for Stem Cell Research and Institute for Cell, Animal and Population Biology, University of Edinburgh, Edinburgh, GB
3 shared publications - Marta Ewa Polak
Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton
3 shared publications - Andrés Felipe Vallejo
School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton
2 shared publications - Andrés de la Rocha‐Muñoz
Department of Biochemistry and Molecular Biology, School of Chemistry Complutense University Madrid Spain
2 shared publications - Anna Appios
Department of Pathology, University of Cambridge, Cambridge, UK
2 shared publications Christina Major
University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK
2 shared publications
Latest Publications
Tezepelumab Reverses TSLP ‐Driven Immunometabolic Rewiring in Human cDC2s Underlying Pathogenic Th2 and Dysfunctional Treg Responses
Background: Thymic stromal lymphopoietin (TSLP) is a key epithelial alarmin involved in the initiation and maintenance of type 2 inflammatory airway diseases. Although tezepelumab, the first approved anti‐TSLP monoclonal antibody, has shown robust clinical efficacy in asthma and CRSwNP, the molecular mechanisms underlying its mode of action remain incompletely defined. Objective: To determine whether TSLP induces a pathogenic immunometabolic program in human type 2 conventional dendritic cells (cDC2s) and whether tezepelumab can directly reverse this process. Methods: Purified human circulating cDC2s from healthy non‐atopic donors were stimulated with TSLP in the presence or absence of tezepelumab. cDC2 phenotype, function, metabolism, and T‐cell polarization capacity were assessed. Pathogenic Th2 responses, Treg generation, suppressive function, and metabolic fitness were analyzed. Results: TSLP induced a metabolic rewiring in human cDC2s characterized by increased glycolysis and mitochondrial oxidative phosphorylation. This metabolic hyperactivation was associated with the acquisition of a pro‐type 2 phenotype and required for the induction of pathogenic T‐cell responses. TSLP‐activated cDC2s generated pathogenic Th2 cells and FOXP3 + Tregs with impaired suppressive function and an altered metabolic profile. Tezepelumab effectively reversed TSLP‐induced metabolic and functional reprogramming in cDC2s, thereby limiting pathogenic Th2 polarization while restoring the functional and metabolic properties of induced Tregs. Conclusions: We identify immunometabolic rewiring as a key mechanism of the TSLP–cDC2 axis and provide mechanistic insight into how tezepelumab reshapes pathogenic adaptive immune responses. These results support upstream epithelial alarmin blockade as a strategy to interfere with early disease‐driving immune programs in type 2 inflammatory airway diseases.
Tezepelumab Reverses TSLP ‐Driven Immunometabolic Rewiring in Human cDC2s Underlying Pathogenic Th2 and Dysfunctional Treg Responses
Background: Thymic stromal lymphopoietin (TSLP) is a key epithelial alarmin involved in the initiation and maintenance of type 2 inflammatory airway diseases. Although tezepelumab, the first approved anti‐TSLP monoclonal antibody, has shown robust clinical efficacy in asthma and CRSwNP, the molecular mechanisms underlying its mode of action remain incompletely defined. Objective: To determine whether TSLP induces a pathogenic immunometabolic program in human type 2 conventional dendritic cells (cDC2s) and whether tezepelumab can directly reverse this process. Methods: Purified human circulating cDC2s from healthy non‐atopic donors were stimulated with TSLP in the presence or absence of tezepelumab. cDC2 phenotype, function, metabolism, and T‐cell polarization capacity were assessed. Pathogenic Th2 responses, Treg generation, suppressive function, and metabolic fitness were analyzed. Results: TSLP induced a metabolic rewiring in human cDC2s characterized by increased glycolysis and mitochondrial oxidative phosphorylation. This metabolic hyperactivation was associated with the acquisition of a pro‐type 2 phenotype and required for the induction of pathogenic T‐cell responses. TSLP‐activated cDC2s generated pathogenic Th2 cells and FOXP3 + Tregs with impaired suppressive function and an altered metabolic profile. Tezepelumab effectively reversed TSLP‐induced metabolic and functional reprogramming in cDC2s, thereby limiting pathogenic Th2 polarization while restoring the functional and metabolic properties of induced Tregs. Conclusions: We identify immunometabolic rewiring as a key mechanism of the TSLP–cDC2 axis and provide mechanistic insight into how tezepelumab reshapes pathogenic adaptive immune responses. These results support upstream epithelial alarmin blockade as a strategy to interfere with early disease‐driving immune programs in type 2 inflammatory airway diseases.
- Open Access
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3 + Tregs
Background: A causal relationship between Crohn's disease (CD) and asthma is reported, but the underlying mechanisms are not fully understood. We sought to investigate the role of IgE and IgE‐mediated pathways in the pathophysiology of CD. Methods: 20 CD patients, 10 allergic patients without inflammatory bowel disease, and 10 healthy donors (HD) were included in the study. Total serum IgE was quantified by ELISA. Circulating IgE + and FcεRIα + immune cells, as well as specific CD4 + T cell populations, were determined by flow cytometry. Gene set enrichment signatures from available single‐cell (sc)RNAseq datasets of the intestine from CD patients were analyzed. Purified plasmacytoid dendritic cells (pDCs) from CD patients were cocultured with naïve CD4 + T cells to assess Tregs generation. Results: CD patients, similar to allergic non‐CD patients, displayed significantly higher numbers of circulating IgE + or FcεRIα + immune cells than HD. The percentage of blood IgE + or FcεRIα + pDCs was significantly higher in CD than HD and similar to allergic non‐CD patients. CD patients showed significantly higher numbers of effector memory CD4 + T cells and lower numbers of FOXP3 + Tregs than HD. scRNAseq data from CD patients confirmed that Tregs imbalance and overactivation of IgE‐mediated pathways take place also in gut tissues of children and adults, suggesting IgE could interfere in the pDC‐Tregs axis. In vitro functional experiments demonstrated that IgE‐crosslinking on pDCs from CD patients impairs Treg generation, which was restored by the anti‐IgE mAb omalizumab. Conclusions: IgE might play an unprecedented role in CD by impairing the capacity of pDCs to generate Tregs, which could represent a novel mechanism contributing to CD to be exploited for alternative therapeutic interventions.
Open AccessThe Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3 + Tregs
Background: A causal relationship between Crohn's disease (CD) and asthma is reported, but the underlying mechanisms are not fully understood. We sought to investigate the role of IgE and IgE‐mediated pathways in the pathophysiology of CD. Methods: 20 CD patients, 10 allergic patients without inflammatory bowel disease, and 10 healthy donors (HD) were included in the study. Total serum IgE was quantified by ELISA. Circulating IgE + and FcεRIα + immune cells, as well as specific CD4 + T cell populations, were determined by flow cytometry. Gene set enrichment signatures from available single‐cell (sc)RNAseq datasets of the intestine from CD patients were analyzed. Purified plasmacytoid dendritic cells (pDCs) from CD patients were cocultured with naïve CD4 + T cells to assess Tregs generation. Results: CD patients, similar to allergic non‐CD patients, displayed significantly higher numbers of circulating IgE + or FcεRIα + immune cells than HD. The percentage of blood IgE + or FcεRIα + pDCs was significantly higher in CD than HD and similar to allergic non‐CD patients. CD patients showed significantly higher numbers of effector memory CD4 + T cells and lower numbers of FOXP3 + Tregs than HD. scRNAseq data from CD patients confirmed that Tregs imbalance and overactivation of IgE‐mediated pathways take place also in gut tissues of children and adults, suggesting IgE could interfere in the pDC‐Tregs axis. In vitro functional experiments demonstrated that IgE‐crosslinking on pDCs from CD patients impairs Treg generation, which was restored by the anti‐IgE mAb omalizumab. Conclusions: IgE might play an unprecedented role in CD by impairing the capacity of pDCs to generate Tregs, which could represent a novel mechanism contributing to CD to be exploited for alternative therapeutic interventions.
- Open Access
- 6 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (99) , eadp0344
Convergent evolution of monocyte differentiation in adult skin instructs Langerhans cell identity
Langerhans cells (LCs) are distinct among phagocytes, functioning both as embryo-derived, tissue-resident macrophages in skin innervation and repair and as migrating professional antigen-presenting cells, a function classically assigned to dendritic cells (DCs). Here, we demonstrate that both intrinsic and extrinsic factors imprint this dual identity. Using ablation of embryo-derived LCs in the murine adult skin and tracking differentiation of incoming monocyte-derived replacements, we found intrinsic intraepidermal heterogeneity. We observed that ontogenically distinct monocytes give rise to LCs. Within the epidermis, Jagged-dependent activation of Notch signaling, likely within the hair follicle niche, provided an initial site of LC commitment before metabolic adaptation and survival of monocyte-derived LCs. In the human skin, embryo-derived LCs in newborns retained transcriptional evidence of their macrophage origin, but this was superseded by DC-like immune modules after postnatal expansion. Thus, adaptation to adult skin niches replicates conditioning of LC at birth, permitting repair of the embryo-derived LC network.
- 6 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (99) , eadp0344
Open AccessConvergent evolution of monocyte differentiation in adult skin instructs Langerhans cell identity
Langerhans cells (LCs) are distinct among phagocytes, functioning both as embryo-derived, tissue-resident macrophages in skin innervation and repair and as migrating professional antigen-presenting cells, a function classically assigned to dendritic cells (DCs). Here, we demonstrate that both intrinsic and extrinsic factors imprint this dual identity. Using ablation of embryo-derived LCs in the murine adult skin and tracking differentiation of incoming monocyte-derived replacements, we found intrinsic intraepidermal heterogeneity. We observed that ontogenically distinct monocytes give rise to LCs. Within the epidermis, Jagged-dependent activation of Notch signaling, likely within the hair follicle niche, provided an initial site of LC commitment before metabolic adaptation and survival of monocyte-derived LCs. In the human skin, embryo-derived LCs in newborns retained transcriptional evidence of their macrophage origin, but this was superseded by DC-like immune modules after postnatal expansion. Thus, adaptation to adult skin niches replicates conditioning of LC at birth, permitting repair of the embryo-derived LC network.
- Open Access
Convergent evolution of monocyte differentiation in adult skin instructs Langerhans cell identity
Langerhans cells (LCs) are a unique population of phagocytes programmed within embryonic skin to maintain tissue and immunological homeostasis at the epidermal barrier site. Unique amongst tissue-resident macrophages, LCs play roles in skin innervation and repair, while also functioning as migrating professional antigen presenting cells, a capability classically assigned to dendritic cells (DC). We currently lack insight into the molecular pathways that determine this dichotomy, when they are established, and whether precursors recruited to the adult skin niche access the same instructive signals laid down in utero. Tracking differentiation of monocyte-derived (m)LCs after destruction of embryo-derived cells in murine adult skin, we reveal intrinsic intra-epidermal heterogeneity and selection of MDP-monocytes to by-pass gene programs specifying a macrophage fate. Within the adult skin, we demonstrate that the hair follicle niche provides Notch signals that determine commitment to become resident mLCs. Using a unique human LC dataset, we show that embryo-derived (e)LCs in newborn human skin retain transcriptional evidence of their macrophage origin, but this is superseded by distinct DC-like immune modules after expansion of the eLC network. Thus, convergent differentiation of monocytes within adult skin replicates conditioning of eLC to-wards more immunogenic DC-like cells within post-natal skin.
Open AccessConvergent evolution of monocyte differentiation in adult skin instructs Langerhans cell identity
Langerhans cells (LCs) are a unique population of phagocytes programmed within embryonic skin to maintain tissue and immunological homeostasis at the epidermal barrier site. Unique amongst tissue-resident macrophages, LCs play roles in skin innervation and repair, while also functioning as migrating professional antigen presenting cells, a capability classically assigned to dendritic cells (DC). We currently lack insight into the molecular pathways that determine this dichotomy, when they are established, and whether precursors recruited to the adult skin niche access the same instructive signals laid down in utero. Tracking differentiation of monocyte-derived (m)LCs after destruction of embryo-derived cells in murine adult skin, we reveal intrinsic intra-epidermal heterogeneity and selection of MDP-monocytes to by-pass gene programs specifying a macrophage fate. Within the adult skin, we demonstrate that the hair follicle niche provides Notch signals that determine commitment to become resident mLCs. Using a unique human LC dataset, we show that embryo-derived (e)LCs in newborn human skin retain transcriptional evidence of their macrophage origin, but this is superseded by distinct DC-like immune modules after expansion of the eLC network. Thus, convergent differentiation of monocytes within adult skin replicates conditioning of eLC to-wards more immunogenic DC-like cells within post-natal skin.
- Open Access
- 19 May 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-14
Impaired expression of metallothioneins contributes to allergen-induced inflammation in patients with atopic dermatitis
Regulation of cutaneous immunity is severely compromised in inflammatory skin disease. To investigate the molecular crosstalk underpinning tolerance versus inflammation in atopic dermatitis, we utilise a human in vivo allergen challenge study, exposing atopic dermatitis patients to house dust mite. Here we analyse transcriptional programmes at the population and single cell levels in parallel with immunophenotyping of cutaneous immunocytes revealed a distinct dichotomy in atopic dermatitis patient responsiveness to house dust mite challenge. Our study shows that reactivity to house dust mite was associated with high basal levels of TNF-expressing cutaneous Th17 T cells, and documents the presence of hub structures where Langerhans cells and T cells co-localised. Mechanistically, we identify expression of metallothioneins and transcriptional programmes encoding antioxidant defences across all skin cell types, that appear to protect against allergen-induced inflammation. Furthermore, single nucleotide polymorphisms in the MTIX gene are associated with patients who did not react to house dust mite, opening up possibilities for therapeutic interventions modulating metallothionein expression in atopic dermatitis.
- 19 May 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-14
Open AccessImpaired expression of metallothioneins contributes to allergen-induced inflammation in patients with atopic dermatitis
Regulation of cutaneous immunity is severely compromised in inflammatory skin disease. To investigate the molecular crosstalk underpinning tolerance versus inflammation in atopic dermatitis, we utilise a human in vivo allergen challenge study, exposing atopic dermatitis patients to house dust mite. Here we analyse transcriptional programmes at the population and single cell levels in parallel with immunophenotyping of cutaneous immunocytes revealed a distinct dichotomy in atopic dermatitis patient responsiveness to house dust mite challenge. Our study shows that reactivity to house dust mite was associated with high basal levels of TNF-expressing cutaneous Th17 T cells, and documents the presence of hub structures where Langerhans cells and T cells co-localised. Mechanistically, we identify expression of metallothioneins and transcriptional programmes encoding antioxidant defences across all skin cell types, that appear to protect against allergen-induced inflammation. Furthermore, single nucleotide polymorphisms in the MTIX gene are associated with patients who did not react to house dust mite, opening up possibilities for therapeutic interventions modulating metallothionein expression in atopic dermatitis.